Cardiovascular safety, cancer and Jak-inhibitors: Differences to be highlighted
Maurizio Benucci, Arianna Damiani, Maria Infantino, Mariangela Manfredi, Barbara Lari, Valentina Grossi, Francesca Li Gobbi, Piercarlo Sarzi‐Puttini
Topics & Concepts
TofacitinibMedicineRheumatoid arthritisJanus kinasePopulationOncologyInternal medicinePharmacologyCytokineEnvironmental healthCytokine Signaling Pathways and InteractionsRheumatoid Arthritis Research and TherapiesSystemic Lupus Erythematosus Research